Categories: All postsAnalysts

NeuLion shareholders should take the Endeavor deal, Beacon Securities says

Digital video broadcaster NeuLion (NeuLion Stock Quote, Chart, News: TSX:NLN) Monday announced it has entered into a definitive agreement to be sold to privately-held entertainment company Endeavor for $250-million (all figures in US dollars, unless noted). The deal looks fair, says analyst Gabriel Leung with Beacon Securities, who is recommending that shareholders take the $0.84 (C$1.08) per share on offer.

Shares of NeuLion jumped on Monday morning with the news that it had agreed to be acquired by Beverly Hills-based Endeavor, a merger of the William Morris Agency and the Endeavor Agency and an owner of NeuLion client, UFC.

The friendly deal, which is subject to regulatory approvals and conditions, has reportedly been unanimously approved by NeuLion’s Board of Directors and by the written consent of holders of a majority of NeuLion’s outstanding common stock. The deal is expected to close sometime in Q2 2018.

In a note to clients on Monday, Leung says, “While we’re sad to see another small cap tech company get swallowed up, we feel the valuation is fair particularly given NeuLion’s recent profitability challenges and continued delays in consummating some of the larger opportunities in the pipeline.”

“We also feel the company will be able to better compete for deals with a large backer, particularly against the likes of BAMTech Media (now owned by Disney) who is both providing technology solutions and also acquiring content rights,” he says.

Leung’s revenue and EBITDA estimates for 2018 were $101.6 million and $8.7 million, respectively. The analyst has changed his recommendation from “Speculative Buy” to “Tender” and has moved his target price from C$0.70 to C$1.08.

More Cantech Analysts

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: nln
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

1 day ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

1 day ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

1 day ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

2 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

2 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

2 days ago